sch-60663 and Hyperlipoproteinemia-Type-II

sch-60663 has been researched along with Hyperlipoproteinemia-Type-II* in 1 studies

Other Studies

1 other study(ies) available for sch-60663 and Hyperlipoproteinemia-Type-II

Article	Year
Dyslipidaemia in 2015: Advances in treatment of dyslipidaemia. Nature reviews. Cardiology, 2016, Volume: 13, Issue:2 Topics: Anticholesteremic Agents; Azetidines; Biomarkers; Cholesterol, LDL; Dyslipidemias; Glucuronides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Meta-Analysis as Topic; Proprotein Convertase 9; Proprotein Convertases; Randomized Controlled Trials as Topic; Serine Endopeptidases; Treatment Outcome	2016

Article

Year

Dyslipidaemia in 2015: Advances in treatment of dyslipidaemia.

Nature reviews. Cardiology, 2016, Volume: 13, Issue:2

Topics: Anticholesteremic Agents; Azetidines; Biomarkers; Cholesterol, LDL; Dyslipidemias; Glucuronides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Meta-Analysis as Topic; Proprotein Convertase 9; Proprotein Convertases; Randomized Controlled Trials as Topic; Serine Endopeptidases; Treatment Outcome

2016